Advanced Medical Solutions Group (LON:AMS) Shares Pass Above 200-Day Moving Average of $221.60

Advanced Medical Solutions Group plc (LON:AMS) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 221.60 ($2.72) and traded as high as GBX 223 ($2.74). Advanced Medical Solutions Group shares last traded at GBX 220 ($2.70), with a volume of 399,757 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank restated a “buy” rating and set a GBX 290 ($3.56) price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 20th.

Advanced Medical Solutions Group Price Performance

The company’s 50-day moving average price is GBX 193.35 and its 200-day moving average price is GBX 221.53. The company has a quick ratio of 4.58, a current ratio of 5.53 and a debt-to-equity ratio of 3.78. The firm has a market cap of £450.90 million, a price-to-earnings ratio of 2,336.36, a PEG ratio of 5.08 and a beta of 0.62.

Advanced Medical Solutions Group Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, September 28th were given a GBX 0.70 ($0.01) dividend. The ex-dividend date was Thursday, September 28th. This represents a yield of 0.39%. Advanced Medical Solutions Group’s dividend payout ratio is presently 2,222.22%.

Insider Transactions at Advanced Medical Solutions Group

In related news, insider Eddie Johnson bought 21,174 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The stock was purchased at an average cost of GBX 194 ($2.38) per share, for a total transaction of £41,077.56 ($50,445.24). Corporate insiders own 2.66% of the company’s stock.

About Advanced Medical Solutions Group

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.